CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
4-D navigated stereotactic radiosurgical ablationprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03601832
NCT03601832N/ACompleted
CompareCT.gov

Phase I/II Study of 4-D Navigated Non-invasive Radiosurgical Ablation of Ventricular Tachycardia

University Hospital Ostrava·interventional·Posted Jul 26, 2018·Updated Dec 7, 2022

In Brief

A clinical study evaluating 4-D navigated stereotactic radiosurgical ablation for Ventricular Tachycardia. Completed, enrolled 10 participants across 3 sites.

Detailed Summary

Phase I/II study of 4-D Navigated Non-invasive radiosurgical ablation of ventricular tachycardia (NIRA-VT).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVentricular Tachycardia
CountriesCzechia
CollaboratorsUniversity of Ostrava, Hospital Podlesi, Hospital Nový Jičín

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJul 26, 2018
Enrollment StartAug 1, 2018
Primary CompletionDec 31, 2019
Study CompletionJan 31, 2020
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 7.9 years ago

Interventions

4-D navigated stereotactic radiosurgical ablationprocedure

4-D Navigated Non-invasive radiosurgical ablation of ventricular tachycardia in patients with sustained monomorphic ventricular tachycardia/tachycardias after myocardial infarction.